In addition, the tumor-promotive role of miR-574-5p has been revealed in other types of cancer, such as cervical cancer and nasopharyngeal carcinoma [31,33], respectively targeting QKI and FOXN3, with which interactions were previously discussed in gastric cancer, CRC, and thyroid cancer [13]. Here, QKI is linked to colorectal carcinoma.